Evidence map›Paper›PMID 20129696›Full record

ArticleEuropean journal of cell biology2010

BMP-2 and TGF-beta1 differentially control expression of type II procollagen and alpha 10 and alpha 11 integrins in mouse chondrocytes.

Jérôme Gouttenoire, Carole Bougault, Elisabeth Aubert-Foucher, Emeline Perrier, Marie-Claire Ronzière, Linda Sandell, Evy Lundgren-Akerlund, Frédéric Mallein-Gerin

Abstract read
In one paragraph

Article in European journal of cell biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 39 citations in OpenAlex.

  1. Trial
  2. A review of advanced hydrogels for cartilage tissue engineering.Frontiers in bioengineering and biotechnology · 2024
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Electrospun Polymers in Cartilage Engineering-State of Play.Frontiers in bioengineering and biotechnology · 2020
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Jérôme GouttenoireInstitut de Biologie et Chimie des Protéines, CNRS UMR 5086, Université de Lyon, and IFR 128 BioSciences Gerland-Lyon Sud, 7 passage du Vercors, Lyon F-69367, France.
Carole Bougault
Elisabeth Aubert-Foucher
Emeline Perrier
Marie-Claire Ronzière
Linda Sandell
Evy Lundgren-Akerlund
Frédéric Mallein-Gerin
Université Claude Bernard Lyon 1 · FRInstitut de Biologie et de Chimie des Protéines · FRCentre National de la Recherche Scientifique · FRIdeon Science Park · SEWashington University in St. Louis · US

Funding

FUNCTION AND REGULATION OF CD/RAPR01AR045550 · NIAMS · WASHINGTON UNIVERSITY · PI SANDELL, LINDA J · 1998 to 2013
$4.1M
NIAMS NIH HHS R01 AR045550
6 · The paper itself

Abstract

Bone morphogenetic protein (BMP)-2 and transforming growth factor (TGF)-beta1 are multifunctional cytokines both proposed as stimulants for cartilage repair. Thus it is crucial to closely examine and compare their effects on the expression of key markers of the chondrocyte phenotype, at the gene and protein level. In this study, the expression of alpha 10 and alpha 11 integrin subunits and the IIA/IIB spliced forms of type II procollagen have been monitored for the first time in parallel in the same in vitro model of mouse chondrocyte dedifferentiation/redifferentiation. We demonstrated that TGF-beta1 stimulates the expression of the non-chondrogenic form of type II procollagen, IIA isoform, and of a marker of mesenchymal tissues, i.e. the alpha 11 integrin subunit. On the contrary, BMP-2 stimulates the cartilage-specific form of type II procollagen, IIB isoform, and a specific marker of chondrocytes, i.e. the alpha 10 integrin subunit. Collectively, our results demonstrate that BMP-2 has a better capability than TGF-beta1 to stimulate chondrocyte redifferentiation and reveal that the relative expressions of type IIB to type IIA procollagens and alpha 10 to alpha 11 integrin subunits are good markers to define the differentiation state of chondrocytes. In addition, adenoviral expression of Smad6, an inhibitor of BMP canonical Smad signaling, did not affect expression of total type II procollagen or the ratio of type IIA and type IIB isoforms in mouse chondrocytes exposed to BMP-2. This result strongly suggests that signaling pathways other than Smad proteins are involved in the effect of BMP-2 on type II procollagen expression.

Indexed as

AnimalsBone Morphogenetic Protein 2Cell DifferentiationCells, CulturedChondrocytesCollagen Type IIIntegrin alpha ChainsMiceProcollagenTransforming Growth Factor beta1Bmp2 protein, mouseBone Morphogenetic Protein 2Collagen Type IIintegrin alpha 10Integrin alpha ChainsProcollagenTransforming Growth Factor beta1

Identifiers

PMID20129696
PMCPMC3791590
OpenAlexW2030248348

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.